pimavanserin

Acadia’s schizophrenia drug trial fails to meet primary endpoint
Clinical Trials Arena
Tue, 03/12/24 - 11:20 am
Acadia Pharmaceuticals
clinical trials
schizophrenia
pimavanserin
The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
BioSpace
Mon, 08/14/23 - 11:23 am
depression
Biogen
SAGE Therapeutics
zuranolone
Intra-Cellular Therapies
lumateperone
Alto Neuroscience
ALTO-100
schizophrenia
Karuna Therapeutics
KarXT
Cerevel Therapeutics
emraclidine
Acadia Pharmaceuticals
pimavanserin
Axesome Therapeutics
AXS-05
Alzheimer's agitation
NRx
NRX-101
bipolar disorder
Biohaven
troriluzole
OCD
VistaGen
fasedienol
social anxiety
Schizophrenia: Four major clinical trials to watch in 2023
Clinical Trials Arena
Thu, 04/13/23 - 10:08 pm
clinical trials
schizophrenia
Reviva
brilaroxazine
Newron
evenamide
Sunovion
ulotaront
Acadia Pharma
pimavanserin
5 FDA approval decisions to watch in the second quarter
BioPharma Dive
Mon, 03/29/21 - 11:16 pm
FDA
Biogen
aducanumab
Acadia Pharmaceuticals
pimavanserin
AstraZeneca
vaccines
COVID-19
Sanofi
Avalglucosidase alfa
Pfizer
pneumococcal disease
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
CP Wire
Mon, 09/10/18 - 11:43 am
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Parkinson's Disease Psychosis
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
Mon, 09/10/18 - 09:53 am
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Yahoo/Reuters
Tue, 12/20/16 - 12:29 pm
Acadia
Alzheimer's disease
pimavanserin
Acadia: Approval Likely For Parkinson's Disease Psychosis Drug
Seeking Alpha
Wed, 04/13/16 - 11:56 am
Acadia
Parkinson's Disease Psychosis
pimavanserin
FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
Yahoo/AP
Tue, 03/29/16 - 10:24 pm
FDA
Parkinson's Disease Psychosis
Acadia
advisory panels
pimavanserin
Acadia surges after nabbing 'breakthrough' title for late-stage Parkinson's drug
Fierce Biotech
Tue, 09/2/14 - 11:19 am
Parkinson's Disease
Acadia
pimavanserin
Acadia On Track With Pimavanserin Development Program
Yahoo/Zacks.com
Wed, 08/6/14 - 09:50 am
Acadia
pimavanserin
earnings
Parkinson's Disease Psychosis
Alzheimer's Needs Cures, Not Pyrrhic Victories
Motley Fool
Mon, 07/21/14 - 09:17 am
Alzheimer's disease
pimavanserin
Acadia
Sangamo BioSciences
Valeant Pharmaceuticals
Bexarotene
Merck
BACE inhibitors
AstraZeneca
solanezumab
Eli Lilly
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Yahoo/Benzinga
Thu, 07/3/14 - 12:07 pm
FDA
drug approvals
Acadia
Alexion
InterMune
Merrimack Pharmaceuticals
Soliris
pimavanserin
MM-398
Esbriet
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
3 Drugmakers to Watch in the New Year
Motley Fool
Wed, 12/11/13 - 11:10 am
pimavanserin
Acadia
Zerenex
Keryx
Iclusig
Ariad Pharmaceuticals
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Motley Fool
Thu, 10/17/13 - 08:24 am
Parkinson's Disease
pimavanserin
Acadia
Duodopa
AbbVie
LCIG
AFQ056
Novartis
Acadia And Parkinson's Treatment Hopes
Seeking Alpha
Mon, 10/14/13 - 08:49 am
Parkinson's Disease
Acadia
pimavanserin
Parkinson's Disease Psychosis
2 Companies Offering Hope In the Fight Against Parkinson’s Disease
Wall St. Cheat Sheet
Tue, 10/8/13 - 09:07 am
Parkinson's Disease
Acadia
International Stem Cell Corp
pimavanserin
parthenogenesis
Acadia Targets Pimavanserin NDA For Late 2014
Seeking Alpha
Thu, 08/8/13 - 02:37 pm
pimavanserin
Acadia
Expect Huge Upside to This Biotech Stock as It Approaches FDA Approval
Motley Fool
Mon, 07/15/13 - 10:27 am
FDA
AstraZeneca
Novartis
Acadia
pimavanserin

Pages